期刊文献+

白假丝酵母生物膜研究进展 被引量:2

Advances in research on biofilm of Candida albicans and prevention strategies
原文传递
导出
摘要 白假丝酵母是临床常见的引起医院获得性感染的主要病原菌之一。生物膜的形成是白假丝酵母的重要致病因素,并可使其对药物的抵抗能力大大增强。白假丝酵母生物膜的形成过程包括黏附、增殖、成熟、分散步骤;其结构由多糖、蛋白质及脂质、胞外DNA及周围环境中的一些物质组成;致病因素包括细胞外基质及DNA、生物膜形成及致病相关蛋白、群体感应分子及与其他微生物之间的相互作用。目前的生物膜防治策略主要有研发新型抗菌药、中药单体成分的研究、改良生物医学材料及新型疗法。 Candida albicans is one of the most common pathogens causing hospital-acquired infections.The formation of biofilm is an important pathogenic factor of C.albicans and can greatly enhance its resistance to drugs.The formation process of C.albicans biofilm includes adhesion,proliferation,maturation,and dispersion steps.Its structure is composed of polysaccharides,proteins and lipids,extracellular DNA and some substances in the surrounding environment.Pathogenic factors include extracellular matrix and DNA,biofilm formation,pathogenicity-related proteins,quorum sensing molecules and interactions with other microorganisms.The current biofilm prevention strategies mainly include research and development of new antibacterial drugs,monomer components of traditional Chinese medicine,modified biomedical materials and novel therapies.
作者 黄筱雪 李燕 HUANG Xiao-xue;Li Yan(Chengdu University of TCM,Chengdu,Sichuan 611137,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2019年第21期3350-3354,共5页 Chinese Journal of Nosocomiology
基金 成都中医药大学杏林学者科研基金资助项目(JSZX2018006)
关键词 白假丝酵母 生物膜 形成过程 结构组成 致病因素 防治策略 Candida albicans Biofilm Formation process Structural composition Pathogenic factor Prevention strategy
  • 相关文献

参考文献12

二级参考文献56

  • 1熊英,傅颖媛,况南珍,张文平.黄芩苷抗白念珠菌作用及机制研究[J].中国药理学通报,2004,20(12):1404-1407. 被引量:72
  • 2秦晓峰,吴建华,顾军.白念珠菌黏附基因研究进展[J].中国真菌学杂志,2006,1(3):186-189. 被引量:9
  • 3李秀丽,廖万清.真菌生物膜研究进展[J].中国真菌学杂志,2006,1(5):318-320. 被引量:15
  • 4Traboulsi RS, Mukheijee PK, ChandraJ , et al. Gentian violet exhibits activity against biofilms formed by oral Candida isolates obtained from HIV -infected patients[J] . Antimicrob Agents Chemother,2011,55(6) :3043-3045.
  • 5Cronin S, Chandrasekar PH. Safety of triazole antifungal drugs in patients with cancer[J].J Antimicrob Chemother, 2010,65 ( 3 ) : 410-416.
  • 6d' Enfert C.Biofilms and their role in the resistance of pathogenic Candida to antifungal agents[J] . Curr Drug Targets, 2006, 7 ( 4) : 465-470.
  • 7Xiao L, Madison V, Chau AS, et al. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding[J] . Antimicrob Agents Chemother,2004,48(2) :568-574.
  • 8Chou TC, Chang LP , Li CY , et al. The antiinflammatory and analgesic effects of baicalin in carrageenan -evoked thermal hyperalgesia[J] . Anesth Analg, 2003 ,97 ( 6) : 1724-1729.
  • 9Clinical and Laboratory Standards Institute/National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of Yeast. ApprovedStandard , edn 3; Document M27 - A3[S] . Wayne, P A: Clinical and Laboratory Standards Institute, 2009.
  • 10An M, Shen H, Cao Y, et al.Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans[J] .IntJ Antimicrob Agents,2009,33(3) :258-263.

共引文献74

同被引文献45

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部